amiodarone has been researched along with Coronary Occlusion in 3 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this investigation was to compare the effectiveness of long-term pretreatment with amiodarone (AMIO) and its active metabolite desethylamiodarone (DEA) on arrhythmias induced by acute myocardial infarction in rats." | 7.81 | Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats. ( Baczkó, I; Falkay, G; Leprán, I; Morvay, N; Papp, JG; Sztojkov-Ivanov, A; Varró, A, 2015) |
| "The aim of this investigation was to compare the effectiveness of long-term pretreatment with amiodarone (AMIO) and its active metabolite desethylamiodarone (DEA) on arrhythmias induced by acute myocardial infarction in rats." | 3.81 | Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats. ( Baczkó, I; Falkay, G; Leprán, I; Morvay, N; Papp, JG; Sztojkov-Ivanov, A; Varró, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contou, D | 1 |
| Lecronier, M | 1 |
| Urbina, T | 1 |
| de Prost, N | 1 |
| Morvay, N | 1 |
| Baczkó, I | 1 |
| Sztojkov-Ivanov, A | 1 |
| Falkay, G | 1 |
| Papp, JG | 1 |
| Varró, A | 1 |
| Leprán, I | 1 |
| Chevalier, P | 1 |
| Timour, Q | 1 |
| Morel, E | 1 |
| Bui-Xuan, B | 1 |
3 other studies available for amiodarone and Coronary Occlusion
| Article | Year |
|---|---|
Earlobe Crease in Patient With Chest Pain.
Topics: Aged; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Bundle-Branch Block; Coronary Occlusion; | 2017 |
Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Consciousness | 2015 |
Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model.
Topics: Acute Disease; Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Occlusion | 2012 |